World's Best Scientists 2026 revealed!
Gerrit Jansen

Gerrit Jansen

D-Index & Metrics

Biology and Biochemistry

D-Index
74
Citations
15725
World Ranking
5740
National Ranking
142

Gerrit Jansen publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Gerrit Jansen sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 324 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Gerrit Jansen D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Gerrit Jansen sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 74 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Gerrit Jansen is affiliated with Amsterdam UMC in the Netherlands and has contributed extensively to the field of medicine, with a focus on several subfields including rheumatology, molecular biology, immunology, oncology, and public health. Their body of research spans a range of topics, prominently addressing rheumatoid arthritis, acute lymphoblastic leukemia, systemic lupus erythematosus, autoimmune and inflammatory disorders, immune cells in cancer, RNA modifications and cancer, and RNA research and splicing.

Among their recent publications are several papers that reflect this broad scope of investigation. Notable papers include:

  • The role of alternative splicing in cancer: From oncogenesis to drug resistance, 2020, Drug Resistance Updates
  • First in man study of [18F]fluoro-PEG-folate PET: a novel macrophage imaging technique to visualize rheumatoid arthritis, 2020, Scientific Reports
  • Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds, 2020, British Journal of Cancer
  • Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia, 2020, PLoS ONE
  • Identification of Metabolic Biomarkers in Relation to Methotrexate Response in Early Rheumatoid Arthritis, 2020, Journal of Personalized Medicine

Jansen has frequently published in venues such as Annals of the Rheumatic Diseases, Frontiers in Immunology, Resuscitation, Scientific Reports, and PLoS ONE. These journals cover a mixture of clinical and biomedical research, highlighting the multidisciplinary nature of their work.

The scientist has collaborated often with several co-authors, indicating a network of recurring partnerships in their research projects. Frequent co-authors include Róbert de Jonge, Jacqueline Cloos, Marry Lin, Ittai B. Muller, and Conny J. van der Laken.

Primary research topics covered by Jansen encompass:

  • Rheumatoid Arthritis Research and Therapies
  • Acute Lymphoblastic Leukemia research
  • Systemic Lupus Erythematosus Research
  • Autoimmune and Inflammatory Disorders Research
  • Immune cells in cancer
  • RNA modifications and cancer
  • RNA Research and Splicing

Overall, Gerrit Jansen's contributions lie at the intersection of clinical medicine and molecular biology, with a distinct emphasis on understanding disease mechanisms and therapeutic responses related to autoimmune diseases and cancer.

Best Publications

  • Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.

    Jan Hendrik Hooijberg;Henk J. Broxterman;Marcel Kool;Yehuda G. Assaraf

  • Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein

    Ruud Oerlemans;Niels E. Franke;Yehuda G. Assaraf;Jacqueline Cloos

  • Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism

    G.J Peters;H.H.J Backus;S Freemantle;B van Triest

  • Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance

    Kristy J. Gotink;Henk J. Broxterman;Mariette Labots;Richard R. de Haas

  • Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases.

    R. J. A. Wanders;P. Vreken;S. Ferdinandusse;G. A. Jansen

  • Drug resistance in pancreatic cancer: Impact of altered energy metabolism.

    Cristoforo Grasso;Gerrit Jansen;Elisa Giovannetti;Elisa Giovannetti

  • Polymorphisms in folate-related genes and risk of pediatric acute lymphoblastic leukemia.

    Robert de Jonge;Wim J. E. Tissing;Wim J. E. Tissing;Jan Hendrik Hooijberg;Gerrit Jansen

  • Impaired bortezomib binding to mutant beta 5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells.

    N E Franke;D Niewerth;Y G Assaraf;J van Meerloo

  • Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.

    B. Van Triest;H. M. Pinedo;Y. Van Hensbergen;K. Smid

  • Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression

    Jennifer Sigmond;Harold H.J. Backus;Dorine Wouters;Olaf H. Temmink

  • A Structurally Altered Human Reduced Folate Carrier with Increased Folic Acid Transport Mediates a Novel Mechanism of Antifolate Resistance

    Gerrit Jansen;Robert Mauritz;Stavit Drori;Hannah Sprecher

  • Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome

    Christian M Zwaan;Gertjan J L Kaspers;Rob Pieters;Karel Hählen

  • Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients.

    Joost W. Van Der Heijden;Ruud Oerlemans;Ben A. C. Dijkmans;Huiling Qi

  • Molecular basis of resistance to proteasome inhibitors in hematological malignancies

    Denise Niewerth;Gerrit Jansen;Yehuda G. Assaraf;Sonja Zweegman

  • The role of alternative splicing in cancer: From oncogenesis to drug resistance.

    Rocco Sciarrillo;Anna Wojtuszkiewicz;Yehuda G. Assaraf;Gerrit Jansen

  • Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia.

    Marianne G. Rots;Marianne G. Rots;Rob Pieters;Rob Pieters;Godefridus J. Peters;Godefridus J. Peters;Paul Noordhuis;Paul Noordhuis

  • In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells

    Katja Wosikowski;Elfi Biedermann;Benno Rattel;Norbert Breiter

  • The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates.

    Peter Wielinga;Jan Hendrik Hooijberg;Sjofn Gunnarsdottir;Ietje Kathmann

  • Bortezomib resistance in multiple myeloma is associated with increased serine synthesis

    Esther A. Zaal;Wei Wu;Gerrit Jansen;Sonja Zweegman

  • Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs--from bench to bedside.

    Joost W van der Heijden;Ben A C Dijkmans;Rik J Scheper;Gerrit Jansen

Frequent Co-Authors

Yehuda G. Assaraf
Yehuda G. Assaraf Technion – Israel Institute of Technology
Godefridus J. Peters
Godefridus J. Peters Gdańsk Medical University
George L. Scheffer
George L. Scheffer VU University Medical Center
Willem F. Lems
Willem F. Lems Vrije Universiteit Amsterdam
Sonja Zweegman
Sonja Zweegman Amsterdam UMC
Rik J. Scheper
Rik J. Scheper Amsterdam University Medical Centers
Ben A. C. Dijkmans
Ben A. C. Dijkmans Amsterdam UMC
Marianne G. Rots
Marianne G. Rots University Medical Center Groningen
Adriaan A. Lammertsma
Adriaan A. Lammertsma VU University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Gerrit Jansen

Trending Scientists

Recently Published Articles